Back to Search Start Over

The German National Registry of Primary Immunodeficiencies (2012–2017)

Authors :
Sabine M. El-Helou
Anika-Kerstin Biegner
Sebastian Bode
Stephan R. Ehl
Maximilian Heeg
Maria E. Maccari
Henrike Ritterbusch
Carsten Speckmann
Stephan Rusch
Raphael Scheible
Klaus Warnatz
Faranaz Atschekzei
Renata Beider
Diana Ernst
Stev Gerschmann
Alexandra Jablonka
Gudrun Mielke
Reinhold E. Schmidt
Gesine Schürmann
Georgios Sogkas
Ulrich H. Baumann
Christian Klemann
Dorothee Viemann
Horst von Bernuth
Renate Krüger
Leif G. Hanitsch
Carmen M. Scheibenbogen
Kirsten Wittke
Michael H. Albert
Anna Eichinger
Fabian Hauck
Christoph Klein
Anita Rack-Hoch
Franz M. Sollinger
Anne Avila
Michael Borte
Stephan Borte
Maria Fasshauer
Anja Hauenherm
Nils Kellner
Anna H. Müller
Anett Ülzen
Peter Bader
Shahrzad Bakhtiar
Jae-Yun Lee
Ursula Heß
Ralf Schubert
Sandra Wölke
Stefan Zielen
Sujal Ghosh
Hans-Juergen Laws
Jennifer Neubert
Prasad T. Oommen
Manfred Hönig
Ansgar Schulz
Sandra Steinmann
Klaus Schwarz
Gregor Dückers
Beate Lamers
Vanessa Langemeyer
Tim Niehues
Sonu Shai
Dagmar Graf
Carmen Müglich
Marc T. Schmalzing
Eva C. Schwaneck
Hans-Peter Tony
Johannes Dirks
Gabriele Haase
Johannes G. Liese
Henner Morbach
Dirk Foell
Antje Hellige
Helmut Wittkowski
Katja Masjosthusmann
Michael Mohr
Linda Geberzahn
Christian M. Hedrich
Christiane Müller
Angela Rösen-Wolff
Joachim Roesler
Antje Zimmermann
Uta Behrends
Nikolaus Rieber
Uwe Schauer
Rupert Handgretinger
Ursula Holzer
Jörg Henes
Lothar Kanz
Christoph Boesecke
Jürgen K. Rockstroh
Carolynne Schwarze-Zander
Jan-Christian Wasmuth
Dagmar Dilloo
Brigitte Hülsmann
Stefan Schönberger
Stefan Schreiber
Rainald Zeuner
Tobias Ankermann
Philipp von Bismarck
Hans-Iko Huppertz
Petra Kaiser-Labusch
Johann Greil
Donate Jakoby
Andreas E. Kulozik
Markus Metzler
Nora Naumann-Bartsch
Bettina Sobik
Norbert Graf
Sabine Heine
Robin Kobbe
Kai Lehmberg
Ingo Müller
Friedrich Herrmann
Gerd Horneff
Ariane Klein
Joachim Peitz
Nadine Schmidt
Stefan Bielack
Ute Groß-Wieltsch
Carl F. Classen
Jessica Klasen
Peter Deutz
Dirk Kamitz
Lisa Lassay
Klaus Tenbrock
Norbert Wagner
Benedikt Bernbeck
Bastian Brummel
Eusebia Lara-Villacanas
Esther Münstermann
Dominik T. Schneider
Nadine Tietsch
Marco Westkemper
Michael Weiß
Christof Kramm
Ingrid Kühnle
Silke Kullmann
Hermann Girschick
Christof Specker
Elisabeth Vinnemeier-Laubenthal
Henriette Haenicke
Claudia Schulz
Lothar Schweigerer
Thomas G. Müller
Martina Stiefel
Bernd H. Belohradsky
Veronika Soetedjo
Gerhard Kindle
Bodo Grimbacher
Al-Herz, Waleed
Source :
Frontiers in Immunology, Vol 10 (2019), FRONTIERS IN IMMUNOLOGY, Frontiers in Immunology, Frontiers in immunology 10, 1272 (2019). doi:10.3389/fimmu.2019.01272
Publication Year :
2019
Publisher :
Frontiers Media S.A., 2019.

Abstract

Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment. peerReviewed

Details

Language :
English
ISSN :
16643224
Volume :
10
Database :
OpenAIRE
Journal :
Frontiers in Immunology
Accession number :
edsair.doi.dedup.....548173fd8c7c0b6b3554a9823dcf9999